Ross Harding

Ross Harding is an experienced clinical research professional currently serving as Senior Manager, Clinical Study Lead at Regeneron since January 2022, where responsibilities include leading early development clinical studies for rare diseases and acting as Program Operations Lead. Prior experience spans over 12 years at Roche in various roles including Study Leader Team Lead, Clinical Research Study Leader, and Global Studies Manager, overseeing global teams and managing oncology studies across multiple countries. Earlier in the career, roles at GlaxoSmithKline included Principal Clinical Research Scientist and Senior Study Manager, focusing on respiratory and HIV therapeutic areas, with extensive experience in leading early phase clinical studies and managing large global clinical trials. Ross Harding holds a PhD in Biological Chemistry, an MRes in Organic Synthetic Chemistry, and a BSc (HONS) in Medicinal Chemistry, all from reputable universities in the UK.